Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer. - Fernandez KA; Chowdhury AS; Bonczkowski A; Allen PD; Campbell MH; Lee DS; Malhotra C; Page BR; Mulford DA; Ortiz CE; Santa Maria PL; Kullar P; et al. (JCI insight, 2025)